FindTrial
Sign In

SAFETY AND EFFICACY IN MANAGING VAGINAL INFECTIONS

A COMPARATIVE STUDY IN DETERMINING THE SAFETY AND EFFICACY OF ANTIMICROBIALS WITH PROBIOTICS AND WITHOUT PROBIOTICS IN VAGINAL INFECTIONS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039169
Enrollment
112
Registered
2022-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N761- Subacute and chronic vaginitis

Interventions

Intervention1: Vaginal infections: Treated with Antimicrobial(Tab METRONIDAZOLE 400mg BD for 7 days) and Probiotics OD for 14 days Control Intervention1: Vaginal infections: Treated with only antimicr

Sponsors

Chettinad Hospital and Research Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All reproductive age women(18-39 years) with vaginal discharge and without any known gynaecological disorders.

Exclusion criteria

Exclusion criteria: Women with chronic inflammatory or autoimmune conditions Women with poorly controlled Diabetes Mellitus Women with sexually transmitted infections Women currently on treatment with antimicrobials either topical or oral Women on long term corticosteroids use Women with contraceptives/ intrauterine devices Pregnant women Lactating mothers

Design outcomes

Primary

MeasureTime frame
To determine the effect of administering antimicrobials and probiotics in reproductive women with vaginal infectionTimepoint: Baseline, 2 weeks and 4 weeks—

Secondary

MeasureTime frame
To evaluate the reduction in the incidence of vaginal infectionsTimepoint: 2 weeks, 4 weeks—

Countries

India

Contacts

Public ContactDr Soundarya

Chettinad Hospital and Research Institute

cranuradha@yahoo.com9444452148

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026